The prognostic significance of bone marrow levels of neurofibromatosis‐1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndrome

This publication has 27 references indexed in Scilit:

• Simplified reverse dot blot analyses for detecting ras oncogene mutations
  Molecular Diagnosis, 1997
• Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells
  Nature Genetics, 1996
• Nf1 deficiency causes Ras-Dediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia
  Nature Genetics, 1996
• Distribution of 13 truncating mutations in the neurofibromatosis 1 gene
  Human Molecular Genetics, 1995
• Analysis of mutations of neurofibromatosis type 1 gene and N‐ ras gene in acute myelogenous leukemia
  The International Journal of Cell Cloning, 1995
• Screening for truncated NF1 proteins
  Nature Genetics, 1994
• The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia: Proposals by the French ‐ American ‐ British Cooperative Leukaemia Group
  British Journal of Haematology, 1994
• Loss of The Normal NF1 Allele from the Bone Marrow of Children with Type 1 Neurofibromatosis and Malignant Myeloid Disorders
  New England Journal of Medicine, 1994
• Molecular basis of neurofibromatosis type 1 (NF1): Mutation analysis and polymorphisms in the NF1 gene
  Human Mutation, 1994
• Somatic mutations in the neurofibromatosis 1 gene in human tumors
  Cell, 1992